The Wyoming Department of Health's HIV/AIDS Treatment and ADAP Program provides persons living with HIV/AIDS access to comprehensive health care and other supportive services. These programs serve as the payer of last resort for persons who are uninsured, under-insured, or are otherwise unable to access medical treatment. Funding for these programs is provided, in part, by grants from the United States Department of Health and Human Services, Health Resources Services Administration, and the United States Department of Housing and Urban Development.
An orexigenic , or appetite stimulant , is a drug , hormone , or compound that increases appetite and may induce hyperphagia . This can be a naturally occurring neuropeptide hormone such as ghrelin , orexin or neuropeptide Y ,   or a medication which increases hunger and therefore enhances food consumption . Usually appetite enhancement is considered an undesirable side effect of certain drugs as it leads to unwanted weight gain ,    but sometimes it can be beneficial and a drug may be prescribed solely for this purpose, especially when the patient is suffering from severe appetite loss or muscle wasting due to cystic fibrosis , anorexia , old age , cancer or AIDS .      There are several widely used drugs which can cause a boost in appetite, including tricyclic antidepressants (TCAs), tetracyclic antidepressants , natural or synthetic cannabinoids , first-generation antihistamines , most antipsychotics and many steroid hormones .
All controlled substance records required to be kept by the registrant-transferor shall be transferred to the registrant-transferee. Responsibility for the accuracy of records prior to the date of transfer remains with the transferor, but responsibility for custody and maintenance shall be upon the transferee.
If the registrant acquiring the pharmacy owns at least one other pharmacy licensed in the same state as the pharmacy being transferred, the registrant may apply for a new DEA registration prior to the date of transfer. DEA will issue a registration which will authorize the registrant to obtain controlled substances at the time of transfer, but the registrant may not dispense controlled substances until the pharmacy has been issued a valid state pharmacy license.